Menu

  • Transcatheter Aortic Valve Replacement
  • Procedure & Performance
  • Clinical Evidence
  • Education & Resources
  • Treating ssAS

    • The problem

    250,000

    people in the United States are diagnosed annually with ssAS.1–9

    48%

    of those patients are undertreated nationally.1–10

    More than 120,000

    remain untreated.8

    Women are
    up to 35%

    less likely than men to be treated for aortic valve replacement (AVR).11

    Medical management isn’t enough.

    If left untreated, average patient survival is just 50% at two years.12

     

    Symptomatic severe aortic stenosis can be fatal.

    Aortic stenosis is among the most common of all valvular heart diseases and continues to increase as our population ages.13 ssAS can be fatal if left untreated.

    Once symptoms begin, survival is cut short.12

    Aortic valve replacement greatly improves the rate of survival.

    “Mortality difference for people with symptoms of aortic stenosis treated with aortic valve replacement versus those not undergoing this procedure is one of the most striking in medicine.“13

    For women, the difference in survival is even starker.

     

    If women do receive treatment, they have a lower mortality rate,14 excellent outcomes compared to SAVR,15 and superior valve performance to the SAPIEN™* platform.16

    Patients with ssAS: operated versus unoperated ssAS survival rates13,17

    Urgency is everything for ssAS patients.

    Detect the murmur.

    You can help save more lives by recognizing the symptoms of ssAS early on.

    Remember to:

    1. Listen for the murmur.
    2. Order an echocardiogram.
    3. Refer patients to a heart valve team without delay.

    Learn about determining the severity of aortic stenosis and when to refer patients to the heart team.

    Experts share their experiences assessing and treating patients with severe aortic stenosis.

    Refer your ssAS patients to the heart valve team.

    Follow updated ACC/AHA guidelines.

    “Patients with severe valvular heart disease (VHD) should be evaluated by a multidisciplinary heart valve team when intervention is considered.”

    Understanding severe symptomatic aortic stenosis from a patient point of view

    90%

    of patients with heart valve disease are influenced by conversations with their doctor when making ssAS treatment decisions.18

    It’s easier to help patients when you know what they’re thinking. The insights gathered from a national survey conducted by heart-valve-surgery.com, with support from Medtronic, can help you better understand the heart valve patient experience.

    View the survey (open in new window)

    Share this resource with your patients and help them learn more about their condition and find a supportive community of other patients diagnosed with ssAS.

    Additional information

    Inquiries about referring patients or becoming a study site?

    Email us

    Connect with us on social.

    LinkedIn: Medtronic Cardiac and Vascular